Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 8/20 | 0.44 |
| ▸ | NTMT1 | Q9BV86 | 2/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31593253 | 0.94 | APLNR (0.50) | APLNROPRM1OPRK1 | |
| SCHEMBL31593304 | 0.93 | APLNR (0.47) | APLNROPRM1OPRK1 | |
| SCHEMBL31593298 | 0.89 | APLNR (0.41) | APLNROPRM1OPRK1 | |
| SCHEMBL31468804 | 0.88 | NAA50 (0.36) | APLNR | |
| SCHEMBL30531335 | 0.87 | NMUR2 (0.42) | APLNROPRM1 | |
| SCHEMBL30064441 | 0.87 | F2 (0.41) | APLNRNTMT1F2OPRM1OPRK1 | |
| SCHEMBL29569370 | 0.87 | APLNR (0.49) | APLNROPRM1OPRK1 | |
| SCHEMBL29496458 | 0.86 | NMUR2 (0.41) | APLNRNTMT1F2OPRM1OPRK1 | |
| SCHEMBL11231542 | 0.86 | OPRM1 (0.46) | F2OPRM1OPRK1 | |
| SCHEMBL11231534 | 0.86 | OPRM1 (0.46) | F2OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025030099-A1 | NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY | SAREPTA THERAPEUTICS, INC. (US) | 2025-02-06 | — | — | WO | disclosed |